Ivermectin "Carefarm" 3 mg tabletter Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

ivermectin "carefarm" 3 mg tabletter

orifarm a/s - ivermectin - tabletter - 3 mg

Iverprasip 3 mg tabletter Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

iverprasip 3 mg tabletter

nordic prime aps - ivermectin - tabletter - 3 mg

Ivermectin "Nordic Prime" 3 mg tabletter Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

ivermectin "nordic prime" 3 mg tabletter

nordic prime aps - ivermectin - tabletter - 3 mg

Cinqaero Evrópusambandið - danska - EMA (European Medicines Agency)

cinqaero

teva b.v. - reslizumab - astma - andre systemiske lægemidler mod obstruktiv sygdomme, - cinqaero er indiceret som add-on-behandling hos voksne patienter med alvorlig eosinofil astma utilstrækkeligt kontrolleret trods inhalationskortikosteroider med høj dosis plus et andet lægemiddel til vedligeholdelsesbehandling.

Nucala Evrópusambandið - danska - EMA (European Medicines Agency)

nucala

glaxosmithkline trading services - mepolizumab - astma - medicin for obstruktiv sygdomme, - severe eosinophilic asthmanucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adults, adolescents and children aged 6 years and older. chronic rhinosinusitis with nasal polyps (crswnp)nucala is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate control. eosinophilic granulomatosis with polyangiitis (egpa)nucala is indicated as an add-on treatment for patients aged 6 years and older with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (egpa). hypereosinophilic syndrome (hes)nucala is indicated as an add-on treatment for adult patients with inadequately controlled hypereosinophilic syndrome without an identifiable non-haematologic secondary cause.

Xolair Evrópusambandið - danska - EMA (European Medicines Agency)

xolair

novartis europharm limited - omalizumab - asthma; urticaria - medicin for obstruktiv sygdomme, - allergiske asthmaxolair er indiceret hos voksne, unge og børn (6 til.

Clobex 500 mikrogram/g shampoo Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

clobex 500 mikrogram/g shampoo

galderma nordic ab - clobetasolpropionat - shampoo - 500 mikrogram/g

Clobex 500 mikrogram/g shampoo Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

clobex 500 mikrogram/g shampoo

2care4 aps - clobetasolpropionat - shampoo - 500 mikrogram/g

Clobex 500 mikrogram/g shampoo Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

clobex 500 mikrogram/g shampoo

orifarm a/s - clobetasolpropionat - shampoo - 500 mikrogram/g

Trica 20 mg/ml injektionsvæske, suspension Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

trica 20 mg/ml injektionsvæske, suspension

riemser pharma gmbh - triamcinolonhexacetonid - injektionsvæske, suspension - 20 mg/ml